These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11920733)
1. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. McKay JA; Douglas JJ; Ross VG; Curran S; Loane JF; Ahmed FY; Cassidy J; McLeod HL; Murray GI J Pathol; 2002 Apr; 196(4):386-93. PubMed ID: 11920733 [TBL] [Abstract][Full Text] [Related]
2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741 [TBL] [Abstract][Full Text] [Related]
4. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis. Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423 [TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis. Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561 [TBL] [Abstract][Full Text] [Related]
7. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083 [TBL] [Abstract][Full Text] [Related]
8. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1. Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060 [TBL] [Abstract][Full Text] [Related]
9. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624 [TBL] [Abstract][Full Text] [Related]
10. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
11. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma. Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pasz-Walczak G; Kordek R Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis. Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232 [TBL] [Abstract][Full Text] [Related]
15. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. Krecicki T; Smigiel R; Fraczek M; Kowalczyk M; Sasiadek MM J Laryngol Otol; 2004 Sep; 118(9):676-80. PubMed ID: 15509364 [TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma. Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070 [TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization. Palmqvist R; Stenling R; Oberg A; Landberg G J Pathol; 1999 May; 188(1):18-23. PubMed ID: 10398135 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices. Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]